MRTX - Mirati Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - MRTX (1576263)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
25 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2024-01-16
MRTXHickey BenjaminEVP, Chief Commercial OfficerS - Sale$59.02-1,597117,028-1%-$94,255
2024-01-16
MRTXChristensen JamieEVP, Chief Scientific OfficerS - Sale$59.02-1,597155,927-1%-$94,255
2024-01-08
MRTXHickey BenjaminEVP, Chief Commercial OfficerS - Sale$58.92-2,090118,625-2%-$123,143
2024-01-04
MRTXChristensen JamieEVP, Chief Scientific OfficerS - Sale$58.81-1,531157,135-1%-$90,038
2023-12-18
MRTXChristensen JamieEVP, Chief Scientific OfficerS - Sale$57.50-2,387141,645-2%-$137,253
2023-12-13
MRTXHickey BenjaminEVP, Chief Commercial OfficerS - Sale$56.67-2,220103,694-2%-$125,807
2023-09-08
MRTXChristensen JamieEVP, Chief Scientific OfficerS - Sale$35.63-2,388144,032-2%-$85,084
2023-08-11
MRTXBoxer Capital, LLCSee remarksP - Purchase$27.80+1,258,9736,672,789+23%+$34,999,449
2023-08-11
MRTXBoxer Capital, LLCSee remarksP - Purchase$27.80+1,258,9736,672,789+23%+$34,999,449
2023-08-11
MRTXHasnain FaheemDirP - Purchase$27.80+10,79125,841+72%+$299,990
2023-06-02
MRTXStelzer LaurieCFOS - Sale$37.06-4,64780,015-5%-$172,218
2023-05-24
MRTXChristensen JamieEVP, Chief Scientific OfficerS - Sale$45.29-619124,1230%-$28,035
2023-01-18
MRTXCherrington Julie MDirS - Sale$44.66-2,5460-100%-$113,704
2023-01-17
MRTXMeek David D.CEOS - Sale$42.38-3,17961,792-5%-$134,715
2023-01-17
MRTXChristensen JamieEVP, Chief Scientific OfficerS - Sale$42.38-2,24597,878-2%-$95,142
2023-01-17
MRTXHickey BenjaminEVP, Chief Commercial OfficerS - Sale$42.38-1,56647,223-3%-$66,366
2023-01-09
MRTXHickey BenjaminEVP, Chief Commercial OfficerS - Sale$45.37-2,08848,789-4%-$94,733
2023-01-04
MRTXBaum Charles MPres,Founder,Head of R, DS - Sale$46.60-3,648168,777-2%-$169,997
2023-01-04
MRTXChristensen JamieEVP, Chief Scientific OfficerS - Sale$46.60-1,949100,123-2%-$90,823
2022-12-21
MRTXBaum Charles MPres,Founder,Head of R, DS - Sale$40.42-9,092172,425-5%-$367,469
2022-12-21
MRTXHickey BenjaminEVP, Chief Commercial OfficerS - Sale$40.41-3,24850,877-6%-$131,266
2022-12-21
MRTXMeek David D.CEOS - Sale$40.41-4,61664,971-7%-$186,552
2022-12-16
MRTXChristensen JamieEVP, Chief Scientific OfficerS - Sale$43.00-2,410102,072-2%-$103,624
2022-12-02
MRTXChristensen JamieEVP, Chief Scientific OfficerS - Sale$90.19-1,726104,482-2%-$155,667
D
2022-11-28
MRTXBaum Charles MPres,Founder,Head of R, DS - Sale+OE$100.00-69,256127,899-35%-$6,925,600

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top